Can Better Antibodies Disrupt Cell Therapy? - 7investing 7investing

Can Better Antibodies Disrupt Cell Therapy?

The emerging therapeutic modality of bispecific antibodies doesn't get much attention, but it's positioned to dominate immunotherapy.

December 20, 2021

– Advisor: Maxx Chatsko

Industries: Biotechnology  

Please log in or subscribe to 7investing Premium to access this advisor update.